Previously Funded Researchers
See researchers who have made a difference in research we have funded in previous years through our nationwide research awards, showcasing the breadth of the work and scientists we have supported.-
Peter Kaiser, Ph.D.
University of California, Irvine
Drugs to Reactivate Tumor-Killing Ability of p53
-
Sunitha Kaiser, M.D., Ph.D.
University of California, San Francisco
The SHAKE Study: Sustaining High-quality Asthma care for Kids Everywhere
-
Nada Y. Kalaany, PhD
Boston Children’s Hospital
Identifying metabolic alterations in lung cancer-associated cachexia
-
Elham Karamooz, M.D.
Oregon Health & Science University
Learning How Immune System Recognizes TB Bacteria Could Lead to New Vaccine
-
Harry Karmouty-Quintana, Ph.D.
University of Texas Health Science Center at Houston
Investigating Role of Excessively Multiplying Cells in Pulmonary Hypertension
-
Hasmeena Kathuria, M.D.
Boston University, Medical Campus
Shared Decision-Making in Lung Cancer Screening
-
Rohit Katial, M.D.
Professor of Medicine, Associate Vice President of Clinical Research & Industry Relationships Co-Director of the Asthma Institute at National Jewish Health, Helen Wohlberg & Herman Lambert Chair
National Jewish Health Mount Sinai Respiratory Institute
-
Takafumi Kato, Ph.D.
University of North Carolina at Chapel Hill
Investigation of Biophysical Properties of Airway Submucosal Gland Mucus in Cystic Fibrosis
-
Venkateshwar Keshamouni, Ph.D.
University of Michigan
NK Cell-mediated Immunotherapy against Lung Cancer
-
Carla Kim, Ph.D.
Children's Hospital Boston
Using “Organoid” Model of Lung Cancer to Test Treatment
-
Jung-whan Kim, Ph.D.
The University of Texas at Dallas
Protein May Hold Key to New Treatments for Squamous Cell Lung Cancer
-
Edy Kim, MD
Brigham and Women’s Hospital
Seeking Targeted Treatments for Unclassifiable Lung Fibrosis
-
Isaac Kirubakaran Sundar, Ph.D.
University of Rochester
Identifying How Cigarette Smoke Causes Lung Cells to Age Prematurely
-
Koichi Kobayashi, M.D., Ph.D.
Texas A&M Health Science Center
Targeting Two Mutations to Develop New Lung Cancer Therapies
-
Kengo Koike, M.D., Ph.D.
National Jewish Health
Understanding Enzyme Involved in Development of COPD
-
John Koomen, Ph.D.
H. Lee Moffitt Cancer Center & Research Institute
Targeting Kinases in Lung Cancer Treatment
-
James Krings, MD, MSCI
Washington University in St. Louis
Cost Analysis of SMART Therapy to Improve Asthma Outcomes
-
Hrishikesh Kulkarni, M.D.
Washington University in St. Louis
Maintaining Airway Epithelial Cell Survival and Host Defense in Severe Pneumonia
-
Sarah Lacher, PhD
University of Minnesota – Twin Cities
Understanding the Molecular Drivers of Wildfire Smoke-Induced Lung Disease
-
Peggy Lai, MD, MPH
Massachusetts General Hospital
HEPA Cleaner Intervention to Reduce Respiratory Virus Exposure in Schools
-
Peggy Lai, M.D., MPH
Massachusetts General Hospital
How Indoor Air Pollution from Chickens Can Affect Lung Health in Rural Africa
-
Seema Lakdawala, Ph.D.
University of Pittsburgh
Reducing the Spread of Influenza Virus Through the Air
-
Dan Landau, M.D., Ph.D.
New York Genome Center
Using Fragments of DNA in the Blood to Detect Lung Cancer
-
Jason Lang, MD
Duke University School of Medicine
Pulmonary Rehab May Help Children with Obesity and Asthma
-
Monica Lawrence, M.D.
University of Virginia School of Medicine
Targeting Neutrophils in Severe Childhood Asthma
-
Sixto Leal, MD, PhD
University of Alabama at Birmingham
Uncovering Clues to COVID Associated Pulmonary Aspergillosis Mold Infection
-
Ian Lewkowich, Ph.D.
Cincinnati Children's Hospital
Why Do Regulatory T Cells Not Work in People with Allergic Asthma?
-
Chi Li, PhD
University of Louisville Research Foundation, Inc.
Inhibiting Lung Adenocarcinoma Growth by Inducing Apoptosis Independent of Bcl-2 Proteins
-
Dan Li, Ph.D.
Stanford University
Elucidating Enzyme's Role in Pulmonary Arterial Hypertension
-
Bo Liang, PhD
Emory University
Viral Polymerases for RSV and SARS-CoV-2 Could be Key for Prevention and Treatment